Baxter - 38 Year Stock Price History | BAX
Historical daily share price chart and data for Baxter since 1981 adjusted for splits. The latest closing stock price for Baxter as of October 18, 2019 is 87.99.
- The all-time high Baxter stock closing price was 89.78 on September 06, 2019.
- The Baxter 52-week high stock price is 89.93, which is 2.2% above the current share price.
- The Baxter 52-week low stock price is 61.05, which is 30.6% below the current share price.
- The average Baxter stock price for the last 52 weeks is 76.59.
| Baxter Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2019 | 79.2482 | 65.3000 | 89.7800 | 64.4800 | 87.9900 | 33.68% |
| 2018 | 69.8944 | 67.1700 | 77.8000 | 61.4500 | 65.8200 | 1.83% |
| 2017 | 58.0264 | 44.4400 | 66.0500 | 44.4400 | 64.6400 | 45.78% |
| 2016 | 43.8994 | 37.1700 | 49.1600 | 34.7600 | 44.3400 | 16.23% |
| 2015 | 52.9969 | 73.3100 | 73.3100 | 32.2700 | 38.1500 | -47.95% |
| 2014 | 72.2730 | 69.1900 | 77.0000 | 66.4900 | 73.2900 | 5.38% |
| 2013 | 69.3542 | 67.6500 | 74.4300 | 63.8900 | 69.5500 | 4.34% |
| 2012 | 58.0275 | 50.5400 | 68.8100 | 49.0300 | 66.6600 | 34.72% |
| 2011 | 54.3502 | 50.5500 | 62.4100 | 47.6500 | 49.4800 | -2.25% |
| 2010 | 49.9003 | 58.2900 | 61.7100 | 40.4700 | 50.6200 | -13.74% |
| 2009 | 54.0204 | 55.0800 | 60.5000 | 46.4100 | 58.6800 | 9.50% |
| 2008 | 61.4454 | 57.7900 | 71.1500 | 48.5000 | 53.5900 | -7.68% |
| 2007 | 54.7795 | 46.5000 | 61.0900 | 46.3300 | 58.0500 | 25.13% |
| 2006 | 40.9353 | 38.3600 | 47.2100 | 35.4500 | 46.3900 | 23.21% |
| 2005 | 37.2682 | 34.6200 | 40.9500 | 33.3700 | 37.6500 | 9.00% |
| 2004 | 31.4834 | 30.1700 | 34.5900 | 28.7600 | 34.5400 | 13.17% |
| 2003 | 26.5794 | 28.6900 | 31.2000 | 18.5600 | 30.5200 | 9.00% |
| 2002 | 43.1442 | 53.1000 | 59.6000 | 24.2200 | 28.0000 | -47.79% |
| 2001 | 48.4272 | 44.8150 | 55.5000 | 40.7500 | 53.6300 | 21.46% |
| 2000 | 35.8150 | 30.6900 | 44.4400 | 25.9050 | 44.1550 | 40.60% |
| 1999 | 32.7239 | 31.5950 | 37.9700 | 29.3450 | 31.4050 | -2.24% |
| 1998 | 28.6442 | 25.0650 | 33.0000 | 24.3450 | 32.1250 | 27.38% |
| 1997 | 25.1378 | 20.3150 | 29.7500 | 20.3150 | 25.2200 | 23.02% |
| 1996 | 21.9332 | 20.8100 | 23.9375 | 20.0000 | 20.5000 | -2.10% |
| 1995 | 17.7909 | 14.0650 | 21.2500 | 13.5650 | 20.9400 | 46.95% |
| 1994 | 12.7748 | 12.1900 | 14.3150 | 11.0000 | 14.2500 | 16.90% |
| 1993 | 13.4814 | 15.9400 | 15.9400 | 10.1250 | 12.1900 | -24.71% |
| 1992 | 17.9988 | 19.6250 | 20.0650 | 15.3750 | 16.1900 | -19.05% |
| 1991 | 16.9144 | 13.6900 | 20.1900 | 12.8150 | 20.0000 | 43.47% |
| 1990 | 12.3140 | 12.7500 | 14.5000 | 10.3150 | 13.9400 | 11.52% |
| 1989 | 10.7476 | 8.8100 | 12.8100 | 8.8100 | 12.5000 | 41.88% |
| 1988 | 10.3560 | 11.6850 | 12.9350 | 8.2500 | 8.8100 | -22.55% |
| 1987 | 12.1138 | 9.5000 | 14.5600 | 9.1850 | 11.3750 | 18.18% |
| 1986 | 9.0744 | 7.7500 | 10.5600 | 7.6250 | 9.6250 | 22.22% |
| 1985 | 7.3046 | 6.5650 | 8.3100 | 6.2500 | 7.8750 | 19.95% |
| 1984 | 8.1495 | 11.6250 | 12.2500 | 6.0000 | 6.5650 | -43.53% |
| 1983 | 13.3763 | 11.5925 | 15.6575 | 10.6850 | 11.6250 | -3.89% |
| 1982 | 9.6983 | 8.5625 | 12.6250 | 7.8125 | 12.0950 | 44.42% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $44.852B | $11.127B |
| Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $145.598B | 26.57 |
| Medtronic (MDT) | Ireland | $145.585B | 20.43 |
| Stryker (SYK) | United States | $80.642B | 27.89 |
| Boston Scientific (BSX) | United States | $53.170B | 25.79 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $32.725B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $28.438B | 18.20 |
| Coloplast (CLPBY) | Denmark | $25.747B | 41.10 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.481B | 0.00 |
| Terumo (TRUMY) | Japan | $24.495B | 30.57 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $20.928B | 0.00 |
| ResMed (RMD) | United States | $18.924B | 36.06 |
| Sunny Optical Technology (SNPTF) | China | $16.014B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.234B | 54.86 |
| Insulet (PODD) | United States | $9.431B | 558.86 |
| Perrigo (PRGO) | Ireland | $7.400B | 13.63 |
| Canopy Growth (CGC) | Canada | $7.222B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.830B | 20.36 |
| Haemonetics (HAE) | United States | $6.455B | 48.71 |
| William Demant Holdings (WILYY) | Denmark | $5.988B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $5.344B | 27.61 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $4.296B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $4.002B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.680B | 0.00 |
| Neogen (NEOG) | United States | $3.490B | 58.40 |
| NuVasive (NUVA) | United States | $3.398B | 27.09 |
| ICU Medical (ICUI) | United States | $3.237B | 21.00 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $2.634B | 0.00 |
| Quidel (QDEL) | United States | $2.510B | 24.93 |
| Agios Pharmaceuticals (AGIO) | United States | $1.982B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.877B | 40.51 |
| Cardiovascular Systems (CSII) | United States | $1.670B | 0.00 |
| Aphria (APHA) | $1.242B | 0.00 | |
| VAREX IMAGING (VREX) | United States | $1.124B | 25.90 |
| AtriCure (ATRC) | United States | $1.059B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.867B | 14.10 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.854B | 21.78 |
| NanoString Technologies (NSTG) | United States | $0.787B | 0.00 |
| Omeros (OMER) | United States | $0.759B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.734B | 19.29 |
| PetIQ (PETQ) | United States | $0.725B | 17.13 |
| LeMaitre Vascular (LMAT) | United States | $0.689B | 40.82 |
| Cerus (CERS) | United States | $0.624B | 0.00 |
| Surmodics (SRDX) | United States | $0.621B | 118.00 |
| MacroGenics (MGNX) | United States | $0.560B | 0.00 |
| Quanterix (QTRX) | United States | $0.548B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.530B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.523B | 24.23 |
| Owens & Minor (OMI) | United States | $0.459B | 13.76 |
| Meridian Bioscience (VIVO) | United States | $0.427B | 13.32 |
| Utah Medical Products (UTMD) | United States | $0.354B | 25.91 |
| Zynex (ZYXI) | United States | $0.346B | 36.76 |
| BioLife Solutions (BLFS) | United States | $0.339B | 104.19 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.327B | 0.00 |
| Bovie Medical (APYX) | United States | $0.234B | 0.00 |
| United Health Products (UEEC) | United States | $0.208B | 0.00 |
| Vapotherm (VAPO) | United States | $0.177B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.153B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.147B | 0.00 |
| Female Health (VERU) | United States | $0.138B | 0.00 |
| Fonar (FONR) | United States | $0.133B | 9.32 |
| InfuSystems Holdings (INFU) | United States | $0.127B | 0.00 |
| Liberty Health Sciences (LHSIF) | Canada | $0.104B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.097B | 0.00 |
| Chimerix (CMRX) | United States | $0.088B | 0.00 |
| Nephros (NEPH) | United States | $0.087B | 0.00 |
| United-Guardian (UG) | United States | $0.084B | 19.82 |
| MTech Acquisition (KERN) | United States | $0.063B | 0.00 |
| MRI Interventions (MRIC) | United States | $0.058B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.053B | 0.00 |
| ImmuCell (ICCC) | United States | $0.040B | 0.00 |
| Surface Oncology (SURF) | United States | $0.039B | 0.00 |
| Senestech (SNES) | United States | $0.023B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.020B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.018B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.013B | 0.00 |
| Myomo (MYO) | United States | $0.010B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.010B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.007B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.005B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.003B | 0.00 |
